Ypsomed focuses on selling its own products

(PresseBox) ( Burgdorf, )
In addition to the B2B Delivery Systems business with pens and autoinjectors, Ypsomed is to focus in future more on sales of its in-house developed pump systems and pen needles as well as on products marketed under the mylife(TM) Diabetescare brand. In this regard, the Ypsomed Group is planning to sell the German company DiaExpert which trades mainly third-party diabetes products.

The German retailer of diabetes accessories, DiaExpert, is wholly owned by the Ypsomed Group. DiaExpert supplies a wide range of predominantly third-party products for the treatment of diabetes in 9 speciality shops and via an online web shop. Initial talks are being held with potential buyers. No decisions concerning the sale have yet been taken. The focus on selling the company's own mylife(TM) products and in-house developments strengthens the position of Ypsomed on the German diabetes market in the long term and will increase profitability going forward.

In connection with this, the sales company Ypsomed Germany will be restructured. Dr. Eberhard Bauer, Vice President Sales Diabetes Care, will take over as manager until the new organisation has been established.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.